Log in to your Inderes Free account to see all free content on this page.
Dignitana
1.02
SEK
+4.62 %
DIGN
First North Stockholm
Medical Equipment & Services
Health Care
3 following
+4.62%
-32%
-15%
-42.37%
-53.21%
-53%
-86.58%
-88.03%
-65.22%
dignitana.com/investor-relations
Dignitana is active in medical technology. The company's main focus is to develop, manufacture, and distribute medical aids that are primarily used as a scalp cooling system in chemotherapy treatment, where the purpose is to eliminate or greatly reduce hair loss. The company operates worldwide. Dignitana was founded in 2007 has its headquarters located in Lund.
Revenue
86.06M
EBIT %
-17.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
DIGN
Daily low / high price
0.97 / 1.02
SEK
Market cap
82.15M SEK
Turnover
8.6K SEK
Volume
8.5K
Latest videos
Financial calendar
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Agartha AB | 29.8 % | 29.8 % |
| Swedbank Robur Microcap | 7.7 % | 7.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Dignitana AB Publishes Q3 2024 Interim Report
Dignitana AB (publ) appoints Nomination Committee for Annual General Meeting 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio